Catalent Pharma Solutions Overview
Pro stress-test →Catalent is a leading global Contract Development and Manufacturing Organization (CDMO), trusted by pharma, biotech and self-care companies to accelerate the development, manufacturing and delivery of products that improve lives. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply.
Strategic Profile
Pro stress-test →With over 50 facilities on four continents, Catalent has supported more than half the products approved by the Food and Drug Administration in the last ten years and annually produces 70 billion doses for 8,000 products. The company derives its revenues primarily from long-term supply agreements with pharmaceutical customers.
Competitive Landscape
Pro stress-test →Catalent competes with major global CDMOs including Lonza, Samsung BioLogics, and Recipharm. The company maintains competitive advantages through scale, FDA approval track record, diverse technology platforms (oral solids, biologics, softgel, cell/gene therapy), and long-term customer relationships. Regional competitors and specialized boutique CDMOs serve niche segments.
Industry Context
Catalent Pharma Solutions operates in Contract Development and Manufacturing Organizations (CDMO).
Key facts
Founded: 2007 · Headquarters: Tampa, US · Employees: 12,602 · Revenue: $4.42B